Dose Finding Study of L19TNF and Doxorubicin in Patients With STS

Clinical trial NCT04032964 · UNKNOWN

Trial details

NCT number: NCT04032964
Sponsor: Philogen S.p.A.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2019-09-05
Primary completion: 2024-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.